Member Info for CrustyPete

If so, I hope it's in the right direction EE!

26.0 - 26.5p now, so has slipped below that 27.0p "threshold" Quoth.

And still they come.

I wonder whether Phil's references to having to move to Nasdaq to get US investors has removed some of the perceived "immediacy" of the opportunity?

It will be interesting to see where we finish the day. Had anyone suggested that we would finish up 9% today I am sure that most of us would have bitten their arm off but, having seen 18%, "only" 9% now seems a little disappointing. It this the short term price ceiling, before news or an increase in the House Broker target?

Very briefly, blimey that was a quick visit and down juts as quick as it went up! MM's taking advantage of the profit takers? No great surprise if so.

Panmure Gordon and their ilk will have to revise their price target pdq, or they will have to recommend them as a SELL?! ;0)

No! Only joking.....

But yes those targets need an upward revision asap. And as EE reminded us they other day, COS (and hence NAV) only increases from 40% to 60% upon 1SCIB1+ phase 3 trial funding and we can't wait for a NASDAQ listing for that!

Pull your finger out Panmure!

And also that despite absolute familiarity the MHRA approvals are still in process though, now continuing conversations over "small items". So hopefully resolved soon.

Question on EE's point re US investors not being able to "invest" in AIM listed companies. Would that preclude SCLP signing a Partnership or JV with a US based / listed company? If so, as EE suggested it wold be a NASDAQ listing or a full sale.

Yes indeed EE, exactly my thoughts regarding US and , more generally, overseas investors and their inability to invest in an AIM listed companies and, though not stated that has one very direct implication - is that, if they really like the company enough they have no option but to buy it outright.....

Agreed Marcus. An excellent exposition.

That was definitely an hour well spent.

I have downloaded the last hour (Phil's section). If anyone wants me to send it to them just email me.

This discussion is extremely interesting and revealing. Every shareholder should be listening to this. And, yes Wildforce, Phil is really telling them how it is. FDA (and even China) versus MHRA and even!

And we are through 27.0p. Now 27.0 - 27.50 and traded at 27.40.

We need to get past 27.0p and hold....

Great timing - now at 27.0p - our highest sp since December 2022!

Coincidence? ;0)

Phil L'H is now up on the link Marcus posted earlier:

Https://parliamentlive.tv/event/index/bedc34d8-d481-46c3-89c3-5ccd4ff8189c

"M&A activity" I meant to say. Sorry, on the hoof this morning.

Oh and one glaring omission for "reasons to be cheerful" - the tremendous amount of activity in Pharma (particularly cancer research and development) and the fantastic valuations being achieved.

Yes indeed scousemark,but I think the optimism is more driven by the recent news on (1) the partnership with NHS Cancer Launch Pad, (2) FDA approval and fast track status, the proximity of the Phase 3 trials in the US, positive noises from the company about the 30+ names in conversation for funding, JV, partnership et al, greater recognition and coverage in the financial and news media and awards, the seeming disappearance of any overhanging block of institutional shares and the knowledge that there is a very full and imminent pipeline of (positive) news flow to come.

It is the above that has led to that optimism and positivity - the rise in the share price is simply a reflection and recognition of all of the above by the market and investors looking to get a seat at the table. Thankfully many of us had already taken a seat at the party a long time ago and managed to accumulate healthy positions well in advance of it.

But yes, I think our optimism is well placed and agree that £2 may well be exceeded quite significantly in the longer term - if allowed to do so ;0)

Fingers crossed.

You are highly unlikely to find any sellers here - not until £2.00 plus anyway.

And with a similar trading pattern as previously seen after a good day's rise..... profit taking early doors. Likely as not to be followed by those early sales being mopped up with later buying.

Apologies, and agreed EE, I stand corrected. I should have included words like "credible" and "serious" with "offer".